#

Healthcare

: 31
IPO of a company developing treatments for eye diseases/Photo: laowaika
News·
SpyGlass Pharma IPO: developer of eye disease therapy device goes public
The key event of the day will be the decisions of the first Fed meeting in 2026 / Photo: Rob Crandall / Shutterstock
News·
Morning in New York: Fed signals in focus
Highlights for the morning: US duties on Irans partners, the OpenAI deal and Venezuelas market surge
Review·
Highlights for the morning: US duties on Iran's partners, the OpenAI deal and Venezuela's market surge
Morning in New York: Stock market players capitalize on post-holiday momentum
News·
Morning in New York: Stock market players capitalize on post-holiday momentum
Sanofi is expanding its vaccine business. It will buy Dynavax for $2.2 billion
News·
Sanofi is expanding its vaccine business. It will buy Dynavax for $2.2 billion
The main thing for the morning: a pill instead of a shot, ships for the U.S. Navy and $40 billion for Hollywood
Review·
The main thing for the morning: a pill instead of a shot, ships for the U.S. Navy and $40 billion for Hollywood
Freedom Broker: Nektar may jump 22% in two months on potential upbeat trial results
Small Caps·
Freedom Broker: Nektar may jump 22% in two months on potential upbeat trial results
These small-cap healthcare names have rocketed YTD
Small Caps·
These small-cap healthcare names have rocketed YTD
Confident Leadership. Bank of America expects Eli Lilly shares to grow by more than 20%
News·
"Confident Leadership. Bank of America expects Eli Lilly shares to grow by more than 20%
AI stocks have come under pressure. Which sectors are now favored by managers?
News·
AI stocks have come under pressure. Which sectors are now favored by managers?
Shorts are coming after small- and mid-cap stocks. Which names are feeling pressure?
Small Caps·
Shorts are coming after small- and mid-cap stocks. Which names are feeling pressure?
Novo-backed schizophrenia drugmaker MapLight Therapeutics debuts on Nasdaq
News·
+1
·
Novo-backed schizophrenia drugmaker MapLight Therapeutics debuts on Nasdaq
Load more